Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
mintedLeaf was a U.S. consumer wellness company focused on hemp-derived CBD products, including full-spectrum CBD oils, softgels, and topical pain-relief creams. The brand emphasized plant genetics, transparency, third-party lab testing, and extraction methods designed to preserve cannabinoids and terpenes. Its products were marketed for stress, sleep, pain, and recovery rather than as prescription therapeutics. Available evidence indicates the business launched in 2019, operated from Florida, and was acquired in March 2020 by Karibo, after which it appears to have ceased operating as an independent active company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on mintedLeaf.